Welcome to LookChem.com Sign In|Join Free

CAS

  • or

88991-53-1

88991-53-1

Post Buying Request

88991-53-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88991-53-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 88991-53-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,9,9 and 1 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 88991-53:
(7*8)+(6*8)+(5*9)+(4*9)+(3*1)+(2*5)+(1*3)=201
201 % 10 = 1
So 88991-53-1 is a valid CAS Registry Number.

88991-53-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-nitro-3-propan-2-yloxybenzene

1.2 Other means of identification

Product number -
Other names 3-(1-Methylethoxy)nitrobenzene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:88991-53-1 SDS

88991-53-1Relevant articles and documents

[Cp?RhCl2]2-catalyzed alkyne hydroamination to 1,2-dihydroquinolines

Kumaran, Elumalai,Leong, Weng Kee

, p. 1779 - 1782 (2015/05/20)

[Cp?RhCl2]2 catalyzes the formation of 1,2-dihydroquinolines from the reaction of two terminal alkynes and an aniline. This reaction is believed to proceed via an alkyne hydroamination followed by an alkyne insertion.

Method of treating cognitive disorders

-

, (2008/06/13)

The invention concerns cholecystokinin (CCK) antagonists useful in the treatment of cognitive disorders. Especially useful are CCKBantagonists such as CI-988.

3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof

-

, (2008/06/13)

Novel substituted quinazolinones have been found to exhibit specific binding to cholecystokinin (CCK) receptors in the brain and/or peripheral site such as the pancreas and ileum. The quinazolinones are CCK receptor antagonists and find therapeutic applic

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 88991-53-1